Influencing and shaping our sector, BIA update: April - July 2018

This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from April to July 2018.

BIA submission to the Health Select Committee’s inquiry on AMR

The BIA has responded to the Health and Social Care Select Committee’s inquiry into how the government is responding to the challenge of antimicrobial resistance (AMR).

Brexit White Paper – The Future Relationship between UK and the EU

We now have more detail and clarity for the sector following the publication by Government of their Brexit White Paper, which you can read in full here The Paper builds on previous Government communications and provides more public confirmation that UK Government would like the UK to retain regulatory cooperation on medicines with the EU as part of the desired future relationship.